Several studies have analysed the impact of the Mdm2 SNP309 on cancer risk in sporadic and hereditary malignancies and a recently published meta-analysis revealed that there is only little effect on the risk of common cancers from this SNP alone. The gene discussed is MDM2; the disease is cancer.